Trends in outcomes of women with myocardial infarction
undergoing primary angioplasty-Analysis of randomized trials

ENPřihlásit se Přihlásit se (EduID)

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of ...

Přehled o publikaci

J 2023

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials

MOTOVSKA, Zuzana, Ota HLINOMAZ, Michael ASCHERMANN, Jiří JARKOVSKÝ, Michael ZELIZKO et. al.

Základní údaje

Originální název

Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials

Autoři

MOTOVSKA, Zuzana, Ota HLINOMAZ, Michael ASCHERMANN, Jiří JARKOVSKÝ, Michael ZELIZKO, Petr KALA, Ladislav GROCH, Michal SVOBODA, Milan HROMADKA a Petr WIDIMSKY

Vydání

Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2023, 2297-055X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Organizace

Lékařská fakulta – Masarykova univerzita – Repozitář

DOI

http://dx.doi.org/10.3389/fcvm.2022.953567

UT WoS

000913324400001

EID Scopus

2-s2.0-85146448325

Klíčová slova anglicky

myocardial infarction; primary PCI; women; outcome; trends; mortality; therapy management

Návaznosti

LX22NPO5104, projekt VaV. CZECRIN IV, velká výzkumná infrastruktura.

Změněno: 26. 1. 2024 03:45, RNDr. Daniel Jakubík

Anotace

V originále

lt; 0.001). The risk of 30-day mortality decreased by 61% (0.39 [0.17-0.91], p = 0.029). ConclusionThe prognosis of women with MI treated with primary PCI improved substantially with 24/7 regional availability of mechanical reperfusion, performance-enhancing technical progress, and intensive adjuvant antithrombotic therapy. A major modifiable hindrance to achieving this benefit in a broad population of women is the timely diagnosis by health professional services.

Přiložené soubory

https://is.muni.cz/publication/2278220/Trends_in_outcomes_of_women_with_myocardial_infarction_undergoing_primary_angioplasty_-_Analysis_of_randomized_trials.pdf

Citovat

MOTOVSKA, Zuzana, Ota HLINOMAZ, Michael ASCHERMANN, Jiří JARKOVSKÝ, Michael ZELIZKO, Petr KALA, Ladislav GROCH, Michal SVOBODA, Milan HROMADKA a Petr WIDIMSKY. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials. Frontiers in Cardiovascular Medicine. Lausanne: Frontiers, 2023, roč. 9, January 2023, s. 1-11. ISSN 2297-055X. Dostupné z: https://dx.doi.org/10.3389/fcvm.2022.953567.

@article{55749,
   author = {Motovska, Zuzana and Hlinomaz, Ota and Aschermann, Michael and Jarkovský, Jiří and Zelizko, Michael and Kala, Petr and Groch, Ladislav and Svoboda, Michal and Hromadka, Milan and Widimsky, Petr},
   article_location = {Lausanne},
   article_number = {January 2023},
   doi = {http://dx.doi.org/10.3389/fcvm.2022.953567},
   keywords = {myocardial infarction; primary PCI; women; outcome; trends; mortality; therapy management},
   language = {eng},
   issn = {2297-055X},
   journal = {Frontiers in Cardiovascular Medicine},
   title = {Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials},
   url = {https://www.frontiersin.org/articles/10.3389/fcvm.2022.953567/full},
   volume = {9},
   year = {2023}
}

TY  - JOUR
ID  - 55749
AU  - Motovska, Zuzana - Hlinomaz, Ota - Aschermann, Michael - Jarkovský, Jiří - Zelizko, Michael - Kala, Petr - Groch, Ladislav - Svoboda, Michal - Hromadka, Milan - Widimsky, Petr
PY  - 2023
TI  - Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials
JF  - Frontiers in Cardiovascular Medicine
VL  - 9
IS  - January 2023
SP  - 1-11
EP  - 1-11
PB  - Frontiers
SN  - 2297-055X
KW  - myocardial infarction
KW  - primary PCI
KW  - women
KW  - outcome
KW  - trends
KW  - mortality
KW  - therapy management
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2022.953567/full
N2  - lt; 0.001). The risk of 30-day mortality decreased by 61% (0.39 [0.17-0.91], p = 0.029). ConclusionThe prognosis of women with MI treated with primary PCI improved substantially with 24/7 regional availability of mechanical reperfusion, performance-enhancing technical progress, and intensive adjuvant antithrombotic therapy. A major modifiable hindrance to achieving this benefit in a broad population of women is the timely diagnosis by health professional services.
ER  -

MOTOVSKA, Zuzana, Ota HLINOMAZ, Michael ASCHERMANN, Jiří JARKOVSKÝ, Michael ZELIZKO, Petr KALA, Ladislav GROCH, Michal SVOBODA, Milan HROMADKA a Petr WIDIMSKY. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty-Analysis of randomized trials. \textit{Frontiers in Cardiovascular Medicine}. Lausanne: Frontiers, 2023, roč.~9, January 2023, s.~1-11. ISSN~2297-055X. Dostupné z: https://dx.doi.org/10.3389/fcvm.2022.953567.